NeuroMetrix, Inc. (the “Company”), an innovative health care company that develops wearable medical technology and point-of-care diagnostics that help patients and physicians better manage chronic pain, nerve disorders, and associated sleep disturbances, today reported first shipments of the second generation of its wearable therapeutic technology, the SENSUS™ Pain Management System.
     
 
    
    
    
    
        
        eZono AG (“eZono”), a private corporation designing, developing and distributing state of the art tablet ultrasound systems, today announced it received 510(k) clearance from the FDA for its eZono 4000 dedicated procedural guidance system with eZGuide technology, providing any plane freehand navigation.
     
 
    
    
    
    
        
        Using the properties of a smartphone screen to perform blood tests: the device developed by Qloudlab allows at-home analysis in less than a minute. The expanded diagnostics will be used to help people undergoing anticoagulant treatment.
     
 
    
    
    
    
        
        Research and Markets has announced the addition of the "Wearable Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.
     
 
    
    
    
    
        
        Research and Markets has announced the addition of the "Medical Sensors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.
     
 
    
    
    
    
        
        Smith & Nephew, the global medical technology business, and OrthoSensor, the leader in intelligent orthopaedics, announced today an agreement that will enable surgeons to benefit from OrthoSensor's VERASENSE Sensor Assisted Surgery Technology for soft tissue balancing when implanting Smith & Nephew's JOURNEY™ II and LEGION™ Total Knee Systems.
     
 
    
    
    
    
        
        OrthoSensor Inc., the leader in Intelligent Orthopaedics, will be showcasing its VERASENSE Knee System products and one-year clinical outcomes in booth 6929 at the American Academy of Orthopaedic Surgeons (AAOS) 2014 Annual Meeting in New Orleans's Morial Convention Center from March 12 – 14.
     
 
    
    
    
    
        
        Private and public investors are injecting $2 million into a Canadian mobile health innovation that offers hope of preventing thousands of deaths and improving the health of expectant mothers, newborns and children throughout the developing world.
     
 
    
    
    
    
        
        Azoi, a technology company dedicated to helping people improve their lives, today announced Wello – an innovative health monitoring device embedded within a mobile phone case. With just a few powerful sensors, Wello fits onto a smartphone and measures a number of key vitals including blood pressure, electrocardiography (ECG), heart rate, blood oxygen, temperature, lung functions and more – with a high level of accuracy. Fast and easy-to-use, Wello empowers people to track key data, improve awareness of their body's state, and make more informed lifestyle choices.
     
 
    
    
    
    
        
        The new smart sensor technology, which can be woven into any fabric and incorporated into any garment, has been developed by researchers Professor Ahmed Al-Shamma’a, Dr Andrew Shaw, Dr Alex Mason and Dr Stephen Wylie from LJMU's Built Environment and Sustainable Technologies (BEST) Research Institute.
     
 
 
    
                    
                
                
                    
    
        Terms
        
            While we only use edited and approved content for Azthena
            answers, it may on occasions provide incorrect responses.
            Please confirm any data provided with the related suppliers or
            authors. We do not provide medical advice, if you search for
            medical information you must always consult a medical
            professional before acting on any information provided.
        
        
            Your questions, but not your email details will be shared with
            OpenAI and retained for 30 days in accordance with their
            privacy principles.
        
        
            Please do not ask questions that use sensitive or confidential
            information.
        
        Read the full Terms & Conditions.